Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

J-Co leads counteroffensive against bloodstream infections

Citing the human and economic toll of central line-associated bloodstream infections$1 billion a year, with a mortality rate as high as 25 percent in the U.S. alonethe Joint Commission has organized a two-phase project to help healthcare providers globally live out the truism that the safest care is often the most cost-effective care.

DoD, VA agree on joint EHR platform

The Department of Defense (DoD) and the Department of Veterans Affairs (VA) have agreed on the platform for a joint project to create an integrated EHR product both departments are calling iEHR.

JNM: PET/CT steers treatment for patients with esophageal cancer

18F-FDG PET/CT imaging impacted staging in 40 percent of patients newly diagnosed with esophageal cancer and management in 34 percent of patients, according to a study published online May 11 in the Journal of Nuclear Medicine. PET/CT may help physicians direct patients to appropriate treatment, which could translate into survival improvements for patients with locally advanced disease.

Study: Video-assisted surgery, CT lung cancer screening go hand-in-hand

Lung cancer screening with low-dose CT appears to boost the use of minimally invasive thoracic surgery, underscoring the importance of coupling CT screening programs with a dedicated video-assisted thoracic surgery (VATS) program, according to an article detailing results from the Danish Lung Cancer Screening Trial published in the June issue of the Journal of Thoracic Oncology.

AR: BSGI may guide management of women with high-risk breast lesions

Breast-specific gamma imaging (BSGI) provided high sensitivity for the detection of atypical, high-risk breast lesions, which could help physicians identify candidates for preventive treatment, according to a study published in the June issue of Academic Radiology.

FDA: Don't take MS drug with prior CV condition, stroke

The FDA has completed its evaluation of a report of a patient who died after the first dose of a multiple sclerosis drug, fingolimod (Gilenya, Novartis), and determined that the drug is now contraindicated in patients with certain pre-existing or recent (within the last six months) heart conditions or stroke, or who are taking certain anti-arrhythmic medications.

HHS strives for healthcare accountability with web-based tool

In an attempt to keep government accountable for its actions, the U.S. Department of Health and Human Services (HHS) has made available a web-based tool for the public to monitor and measure how the healthcare system performs.

HRS: Electric event sparks discussion

Last week, I trekked up to Boston to cover the 33rd annual scientific sessions of the Heart Rhythm Society (HRS). If you were there, or even if you weren't, you can see from our coverage that the conference was stimulating and incited chatter about electrophysiology as well as its new technologies, drugs and methods.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.